CLINICAL TRIALS PROFILE FOR REMERON SOLTAB
✉ Email this page to a colleague
All Clinical Trials for REMERON SOLTAB
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00834197 ↗ | 15 mg Mirtazapine Orally Disintegrating Tablets, Non-Fasting | Completed | Teva Pharmaceuticals USA | Phase 1 | 2003-07-01 | This study will compare the relative bioavailability (rate and extent of absorption) of 15 mg Mirtazapine (Orally Disintegrating) Tablets manufactured by TEVA Pharmaceutical Industries, Ltd.; distributed by TEVA Pharmaceuticals USA with that of 15 mg REMERON SolTabĀ® Orally Disintegrating Tablets manufactured for Organon Inc. by CIMA Labs Inc. following a single oral dose (1 x 15 mg) in healthy adult subjects under non-fasting conditions. |
NCT00835575 ↗ | 15 mg Mirtazapine Orally Disintegrating Tablets, Fasting | Completed | Teva Pharmaceuticals USA | Phase 1 | 2003-07-01 | This study will compare the relative bioavailability (rate and extent of absorption) of 15 mg Mirtazapine (Orally Disintegrating) Tablets manufactured by TEVA Pharmaceutical Industries, Ltd.; distributed by TEVA Pharmaceuticals USA with that of 15 mg REMERON SolTabĀ® Orally Disintegrating Tablets manufactured for Organon Inc. by CIMA Labs Inc. following a single oral dose (1 x 15 mg) in healthy adult subjects under fasting conditions. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for REMERON SOLTAB
Condition Name
Clinical Trial Locations for REMERON SOLTAB
Trials by Country
Clinical Trial Progress for REMERON SOLTAB
Clinical Trial Phase
Clinical Trial Sponsors for REMERON SOLTAB
Sponsor Name